The first batch of peptides up for discussion includes BPC-157 in ulcerative colitis, KPV in wound healing, and MOTs-C for obesity and osteoporosis
Scheithauer TPM, et al
CrossRef Large-scale screening of HBV epitopes restricted by multiple prevalent HLA-B/C allotypes and routine detection of HBV-specific T cells in CHB patients Yandan Wu, Yu Zhao, Ruixue Ji, Pinqing Li, Huijuan Chen, Fangping Yue, Yi Wu, Jie Qiu, Chuanlai Shen Frontiers in Immunology .2026;[Epub] CrossRef Group-based trajectory modeling for declines in hepatitis B surface antigen over time accurately identifies chronic hepatitis B patients achieving functional cure: a single-center cohort study in China Yuchen Peng, Liping Liu, Xiaoping Wu Annals of Medicine .2026;[Epub] CrossRef Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B Shuaibing Ying, Jinyao Dai, Qiudan Zhang, Yujing Wang, Yina Yu, Zhijuan Zhang, Shaohua Dong, Yichun Zhang, Haoyang Hu, Yuqi Hong, Yi Liu, Yuqi Guo, Haomin Yan, Yunqing Qiu, Yan Lou Alimentary Pharmacology & Therapeutics .2026

Focused on GLP-1 wellness patch formulation with documented 1-year shelf life , suitable for regulated health supplement lines
For people using semaglutide primarily for weight loss, the SELECT data is particularly meaningful
Long-term effect of -glycosidase inhibitor on late dumping syndrome